Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal keratinocyte proliferation is the process by which keratinocytes, the primary cell type in the epidermis, multiply. This process is essential for maintaining skin homeostasis, wound healing, and continuous epidermal renewal. It is regulated by growth factors (like EGF), transcription factors (like Epiprofin), and signaling pathways (ERK/Akt). Dysregulation can lead to hyperproliferative disorders, impaired wound healing, and increased cancer risk.
Varies depending on the regulator involved (e.g., retinoids modulate gene expression, EGF inhibitors block receptor activation).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal Keratinocyte Proliferation (None).